Mounjaro Not Working? Reasons and Next Steps (October 2026)

01 · The core answer

Is Mounjaro really not working, or is it too early to tell?

In most cases the honest answer is that it is too early, or the dose has not yet reached the level where you respond. Mounjaro (tirzepatide) is licensed for weight management in adults and is used alongside a reduced-calorie diet and increased physical activity.¹ The starting weeks on 2.5mg are about adjustment. Some people notice an appetite change and early loss straight away, while others feel little until a higher dose. Both are normal.¹

Different signs have different likely causes, so matching what you notice to what may be going on helps.

02 · Your next move

What to do if Mounjaro isn't working

Start with the plain basics, because they explain most stalled progress. Be honest about portions, because they drift back up over time. Protect protein and activity. Check your sleep and alcohol intake. Then bring your experience to your prescriber, who can discuss whether a dose step-up is appropriate if you are not yet at maximum.¹

A plateau is not a reason to double doses or add unlicensed products.

Keep notes for your review. Record your starting weight, your current dose, how long you have been on it, how hungry you feel, and what you eat on a typical day. Prescribers can do much more with a few weeks of honest notes than with a single weigh-in. The free GLPTrackr companion app can help you log your journey.

If you are already with a prescriber through us, your monthly reviews exist for exactly this conversation. Dose pricing is shown live on the Mounjaro pen page: the standard price of the 2.5mg pen is £169.99 per month, a new customer saves £40 on their first order with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). If you are weighing up your wider options, our weight loss clinic hub explains how treatment, reviews and lifestyle support fit together.

Finally, remember that "not working" often means "not working as fast as I hoped". Trials measured results over many months, and your own pace may be slower or faster than the average. That is a reason to review the plan calmly, not to abandon it in frustration or push the dose beyond what has been prescribed.

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. Individual results vary, and this page is information, not a substitute for medical advice.¹

03 · Early weeks: what is normal

First weeks on Mounjaro: what is normal

The first weeks are an adjustment phase, and what you feel or do not feel tells you little about the final outcome. The 2.5mg starting weeks are about adjustment, and experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose. Both are normal.¹

In those early weeks the starting dose is not designed to deliver the full effect. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹

Early loss also includes water weight, so the trend over weeks matters more than any single weigh-in. Body weight naturally moves up and down with salt, hydration, bowel habits and the time of day. A single reading after a heavy meal can hide real progress, and a single low reading can flatter it. Weigh at a consistent time, record the number, and look at the direction over several weeks.

Early side effects can also confuse the picture. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹ If you feel nauseous or tired, you may feel Mounjaro is "doing something" even if the scale has not moved. Equally, if you feel nothing, that does not mean the medicine is inactive. People differ widely in how they notice it.

Do not judge the medicine on how you feel in the hours after an injection. Judge it on how your appetite, portions and weight trend across several weeks. If appetite feels unchanged after several weeks, write that down and raise it at your review rather than changing anything on your own.

Mounjaro does not work in isolation. It is used alongside a reduced-calorie diet and increased physical activity, so the early weeks are also the time to build the routines that make later doses count. Plan meals, keep protein in each one, and find an activity you can sustain. These healthy habits are what the medicine supports, and they matter more than any single injection day.

Consider also how you are recording progress. Measuring only the scale can miss changes in how clothes fit or how you feel day to day. In trials, weight loss came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures.² Those are trial averages, not individual results, but they are a reminder that the scale is only one signal of health.

If something feels wrong rather than merely slow, speak to your prescriber. Report suspected side effects through the Yellow Card scheme, and read your patient information leaflet for guidance on what to do if symptoms are troublesome.¹³

04 · Dose too low?

Is your Mounjaro dose too low?

Quite possibly, if you are still on the lower rungs of the dose ladder. Mounjaro comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ The lowest strengths are there to help your body adjust, and many people respond more clearly as they move up.

Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures. A sensible 3-month expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.² Slower early progress does not predict failure, because the dose you respond to may still be ahead of you.

Moving up is a clinical decision, not a DIY one. Your prescriber considers how you tolerate the current dose, how your appetite is behaving, and where you are in the plan. Our dose-specific guides can help you set expectations at each stage: the 5mg dose guide, the timeline and expectations guide, the 7.5mg guide, the 10mg guide and the 12.5mg guide.

What you should not do is take matters into your own hands. A plateau is not a reason to double doses or add unlicensed products.¹ Those practices carry risk, and they are outside the licence.

It also helps to know where you are in the plan. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ Responding to a low dose is not the test. The review point comes after you have had a fair run at a dose that suits you.

Tolerability matters too. Some people are held at a lower dose because side effects make going up uncomfortable. If that is you, your prescriber may keep you where you are rather than pushing ahead, and your progress may look slower as a result. That is a reasonable trade-off, and it is a decision to make together with your prescriber, not alone.

If you are wondering whether you have simply outgrown the dose you are on, bring your records to your next review. A clear history of intake, appetite and weight lets the prescriber judge whether a step-up is appropriate, whether to hold, or whether something other than dose is at play.

05 · Still hungry?

Mounjaro not working and still hungry: why appetite may persist

Appetite control varies between people and between doses, so feeling hungry does not by itself mean the medicine has stopped working. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

It supports a reduced-calorie diet; it does not remove the need for one. It helps to ask what kind of hunger you mean. True physical hunger between meals is different from a pull towards food at certain times, such as evenings, or when you are bored, tired or under pressure.

Some practical checks can help before your review. Is each meal built around protein? Are portions creeping up? Are drinks, snacks or alcohol adding more than you realise? Are you sleeping enough? Poor sleep and alcohol are named in the basics prescribers ask you to check when progress stalls.¹ Do not assume the medicine alone should settle every craving.

It is also worth being clear about what Mounjaro does and does not do. Trial results came from people using it alongside diet and exercise, not instead of them.² That means your food and activity choices stay central to the result.

Rather than guess about patterns, note your hunger on a simple daily scale for a few weeks. If a clear pattern shows, your prescriber can use it to talk through the next step.

No food is banned on Mounjaro. The aim is a reduced-calorie diet with protein and activity protected. If certain foods trigger nausea or discomfort for you, note them and discuss them with your prescriber or pharmacist rather than guessing.

If your appetite is not suppressed at all after a fair run, say so at your review. It may be that a dose step-up is appropriate, that a different issue is at play, or that expectations need adjusting. The point is to have a clinical conversation, not to suffer through it or self-adjust.

Finally, treat food cravings with kindness. A treatment that supports appetite does not erase the habits and emotional patterns around eating. Building routines you can sustain is part of the treatment journey, and your prescribing team can point you to support.

06 · Plateaus and stalls

Plateaus: when weight loss slows or stops

A plateau is a normal part of weight loss, not proof that Mounjaro has failed. Weight loss on Mounjaro is not linear — plateaus of a few weeks are normal and expected as the body adapts to a lower weight.¹ Many people lose at a good pace early and then find the scale flat for a while, which can feel like the medicine has "stopped". It is more often the body catching up.

Within the licence, the responses are clear. Review food intake honestly, because portions drift back up. Protect protein and activity. Check the basics, such as sleep and alcohol. Then discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.¹ That is the whole list, and it deliberately avoids shortcuts.

The helpful move is to look back at your records: have portions grown, has activity dropped, has snacking returned?

Does Mounjaro stop working over time? Plateaus are normal, and your response is reviewed by your prescriber. The trend over time is the right measure.¹ If you have been at a dose for a long time with little change, that is a good moment for a review rather than a reason to quit.

Trials give context for the pace. Average results were measured over 72 weeks, which is a long time, and individuals varied. Think in months, not days, and judge progress by trend, not individual weigh-ins.¹ A few flat weeks inside a long journey are not unusual.

Muscle mass and activity are worth a thought. Keeping up protein and some form of resistance or general activity is part of protecting what you want to keep while you lose weight.

What to avoid during a plateau is as important as what to do. Do not double your dose. Do not add unlicensed products or supplements marketed with dramatic weight-loss claims. Do not skip meals in the hope of forcing the scale to move. These reactions add risk and rarely help, and a calm review is better.

If you have stalled at a particular strength, the matching guides may help you frame it: our pages on the 10mg stage and 12.5mg stage cover what to look at when progress slows at higher doses.

07 · Pen and injection issues

Pen, needle and injection problems

If you suspect the pen rather than your response, the first step is to follow the pen's instructions and then contact the pharmacy that supplied it. These are practical problems with practical routes to a solution.

Every order from us includes needles, a sharps bin and injection guidance, and the patient information leaflet explains how to use the KwikPen step by step.¹³ Re-read it if you are unsure. Do not guess at technique, and do not press, hold or repeat the injection based on advice from forums. Follow the pen's instructions.

Storage can matter too. Unopened pens should be kept in the fridge until first use, and they keep until the printed expiry date.¹ Once in use, a KwikPen is licensed for up to 30 days (not above 30°C) out of the fridge. If a pen has been stored outside these conditions, sterility and potency are no longer assured, so check the leaflet and contact the pharmacy rather than using it and hoping for the best.

If you think a pen was faulty, damaged or the wrong item, contact us as soon as you notice. Dispensed prescription medicines cannot be returned except for faulty, damaged or wrong items, so reporting promptly matters. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat, or on 0333 207 0413.

Where did your pen come from? Counterfeit medicines are a real risk with unregulated sellers. Genuine Mounjaro is supplied only after a consultation and prescription, and our supply comes directly through official LillyDirect channels from Eli Lilly's UK distribution. Be wary of anyone offering to supply without a consultation or prescription, and report suspected counterfeits through the MHRA and Yellow Card routes.⁷ A fake or mis-stored product could easily look like "Mounjaro not working".

Not every apparent failure is mechanical. If the pen works as expected and you are following the instructions, the question returns to dose, time and habits. Our page on the injection seeming ineffective goes through the checks in order, from technique to expectations.

Side effects after an injection are a separate matter. If you notice symptoms that worry you, contact your prescriber, and consider reporting them via the Yellow Card scheme.¹⁹ Reporting helps regulators monitor safety, and it is open to patients as well as professionals.

Finally, keep a short log of each injection: the date, the dose, which site you used, and any problems. If you ever need to talk to a pharmacist or prescriber about whether a dose was delivered, that record turns a vague worry into a clear conversation.

08 · What the trials show

What the trials show about average results

Trial averages are useful for context, but they are averages, and your own result may differ. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

The spread matters. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² That tells you a large majority responded at each dose, and it also shows that some did not reach that mark. Being in the minority in a trial is possible, which is why a prescriber review exists.

Look at the timing too. These results were measured at 72 weeks, not in the first few weeks. In the same trial, average weight loss built month by month, with the full averages measured at 72 weeks, not 12.² If you are a few weeks in and comparing yourself with headline figures, you are comparing a snapshot with the finish line.

As a worked example only, for someone starting at 100 kg, 20.9% is about 21 kg. This illustrates how a percentage translates for a particular starting weight; it is a trial average at the highest dose over a long period, not a forecast of what you will lose, and it says nothing about how quickly it might happen.

Are some people resistant to Mounjaro? Responses vary, and your prescriber reviews limited response rather than labelling anyone resistant. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ That is the framework to use, rather than a self-diagnosis based on a few weeks.

Results also extend beyond the scale. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are secondary outcomes and averages, not promises, but they are why prescribers talk about weight management as health management rather than appearance.

Do not stack different trials against each other to decide whether you are doing "well". Different studies had different participants and designs, and only a direct head-to-head trial supports a head-to-head comparison. Use trial figures as general context and rely on your prescriber for your own targets.

If you want to understand what to expect at a given stage, the expectations guide for the 5mg stage sets out a sensible way to read progress without comparing yourself to headline numbers. Keeping expectations realistic is one of the most useful things you can do for your own motivation.

09 · Breaks, restarts and switching

After a break, a restart or a switch

If you stopped Mounjaro and restarted, a muted response can be disappointing, but the first step is to talk to a prescriber rather than choosing your own dose. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

That clearance period explains why a short gap does not instantly reset everything, and why appetite may change gradually after stopping. Restarting is a prescriber decision. Our guide on Mounjaro after a break in treatment explains what to raise at that conversation.

People who tried Mounjaro before and are trying it again often wonder why it feels different. Circumstances change: your starting weight, your routine, your stress levels and your sleep may all be different. Bring these to your prescriber rather than guessing.

Switching provider mid-treatment is another common scenario. Repeat orders re-check suitability, and there is no auto-shipping, so your prescriber stays involved at each step.

If you are weighing up other medicines because Mounjaro seems not to suit you, speak to your prescriber. Different treatments have different licences, dose ladders and side effect profiles. For instance, Wegovy (semaglutide) has a dose ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, and liraglutide is a daily injection supplied at 6mg/ml, unlike once-weekly Mounjaro and Wegovy.

NHS access is part of the picture too. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first.⁴ If you are on the NHS pathway, your review and next steps run through your NHS team.

Whichever route you are on, the principle is the same: changes in dose, product or schedule belong with a prescriber. Never cut your own plan, restart at an arbitrary strength or use leftover pens beyond their in-use window of 30 days (not above 30°C) once started.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · When to speak to a prescriber

When to speak to your prescriber, and what to bring

Speak to your prescriber whenever progress, appetite or side effects are not what you expected, and certainly at your scheduled review. You do not have to wait until you have given up. A conversation after a few flat weeks is far more useful than a decision made in frustration, and prescribers can only adjust a plan they know about.

Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ That is a formal review point. Before then, you can still raise concerns, ask about a step-up, or ask whether anything in your routine could be limiting progress.

What should you bring? Your starting weight and your current weight, ideally as a trend across weeks. Your current dose and how long you have been on it. A short description of your appetite and cravings. A typical day of eating, honestly recorded. Your sleep pattern, your alcohol intake, and your activity. Any side effects, and any other medicines or supplements you take, including over-the-counter products.

The last point deserves emphasis. Tell your prescriber about everything you take. Conditions such as high blood pressure or diabetes may also interact with how your plan is managed, so a full picture helps.

With us, ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team are included, along with side-effect support. Your consultation is free, reviewed by a GPhC-registered prescriber, and the price shown is the price paid with no hidden fees. Registration number GPhC 9012878 is on the public register.

If you are not yet a customer and want a clinical view of whether Mounjaro is right for you, the Mounjaro pen page explains how the consultation works. Orders placed by 3pm are dispatched the same day, with free next-day tracked delivery in temperature-controlled packaging, and all six doses are in stock.

For severe, persistent stomach pain, chest pain, fainting, yellowing of the skin or eyes, or swelling of the face, lips, tongue or throat, get medical help straight away rather than waiting for a review. Report suspected side effects through the Yellow Card scheme.¹⁹ Your safety always comes before your scale.

Lastly, be kind to yourself. Weight management is a long process with ups and downs. A treatment plan that you can follow, review and adapt with professional support is far more likely to serve you than a rushed fix. If Mounjaro still seems not to be working after a proper review, that conversation is the way to find the next step.